Omega Therapeutics, Inc.

OMGACIK 0001850838 · Every Form 4 filed by insiders at this issuer. See financials →

Annual report (10-K)

Latest 10-K filed Mar 28, 2024. Sentiment + YoY language diff vs prior year. Read sections →

Signal:Material rewriteFull-doc fallback

Full filing:tone -0.0130Δ-0.00496% similar+1779/-11 ¶

Sentiment via Loughran-McDonald lexicon · YoY diff via Jaccard similarity + paragraph set difference.

Recent 8-K announcements

Per-item disclosure feed. Item 2.02 is the earnings release.

Feb 24, 2025no items parsed Feb 14, 2025no items parsed Feb 3, 2025no items parsed Jan 28, 2025no items parsed Jan 17, 2025no items parsed

YoY shift: Lean -

Year-over-year tone shift - average net-tone change across Risk Factors and MD&A vs the prior 10-K. This filing is -0.49pp more bearish than last year's.

Why YoY instead of absolute: the LM lexicon has ~6.6× more negative words than positive (legal/risk-disclosure language is heavy on hedging), so every 10-K reads bearish on raw tone. Year-over-year change strips that bias and surfaces the actual shift in management's framing.

Per-snippet highlights

Sentence-level sentiment highlighting with category and subcategory filters is coming once the snippet-scoring pipeline lands. For now, dig into the actual section text on the Sections tab.

Top insiders

Most active reporters at Omega Therapeutics, Inc.

Name	Roles	Filings
Young Richard A	Director	8
Karande Mahesh	OfficerDirector	4
Schade Christian S	Director	4
Afeyan Noubar	Director10% Owner	3
Levy Elliott M.	Director	3

Showing 1-5 of 24

Per pagePage 1 of 5Next

All filings

55 Form 4 / 4-A filings, newest first

Filed	Insider	Top transaction	Shares	Price	Value
Dec 5, 2024	Mehrotra Ravi Director	Holdings only	-	-	-
Nov 26, 2024	Nelson Jennifer Ann Chief Scientific Officer	Holdings only	-	-	-
Nov 15, 2024	Certel Kaan See Remarks · Director	Holdings only	-	-	-
Oct 4, 2024	Rosiello Robert L. Director	Holdings only	-	-	-
Jun 21, 2024	Kender Richard N Director	Holdings only	-	-	-

Showing 1-5 of 55

Per pagePage 1 of 11Next

Real-time Form 4 intelligence. Smarter insider tracking.

Filed		Top transaction	Shares	Price	Value